Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -1.87% | -7.14% | -24.64% |
05-09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.64% | 206M | |
+8.33% | 113B | |
+10.22% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.28% | 17.24B | |
+7.67% | 14.29B | |
+37.63% | 12.52B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- BofA Securities Adjusts Price Target on bluebird bio to $12 From $11, Maintains Buy Rating